Goldman Sachs Downgrades Humana (HUM) to Neutral

Goldman Sachs downgraded Humana (NYSE: HUM) from Buy to Neutral with a price target of $90 (down from $98).

The firm sees more upside in others areas of their coverage. Specifically, the firm's Buy-rated names in managed care include Health Net (NYSE: HNT), Coventry (NYSE: CVH), and WellCare (NYSE: WCG).

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $81.39 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Merck (MRK) PT Raised to $143 at Truist Securities
• Teradyne (TER) PT Raised to $125 at TD Cowen
• Sage Therapeutics (SAGE) PT Lowered to $18 at Truist Securities